| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8573096 | The Journal for Nurse Practitioners | 2018 | 8 Pages |
Abstract
Immunotherapy has emerged as a promising treatment for cancer survivors in the past few years. This new treatment is associated with unique immune-related toxicities that can range from mild to life-threatening. Early recognition, referral, and monitoring by primary care nurse practitioners may improve the quality of life and survival of cancer survivors.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Fedricker D. PhD, ANP-BC, AOCNP,